Canada Pension Plan Investment Board
JAZZ icon

Canada Pension Plan Investment Board’s Jazz Pharmaceuticals JAZZ Stock Holding History

Canada Pension Plan Investment Board’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.3M Buy
112,500
+9,700
+9% +$1.7M 0.01% 487
2025
Q4 		$17.5M Buy
102,800
+16,100
+19% +$2.47M 0.01% 534
2025
Q3 		$11.4M Sell
86,700
-161,800
-65% -$19.4M 0.01% 603
2025
Q2 		$26.4M Buy
248,500
+71,900
+41% +$7.81M 0.02% 421
2025
Q1 		$21.9M Sell
176,600
-12,400
-7% -$1.62M 0.02% 437
2024
Q4 		$23.3M Buy
189,000
+8,000
+4% +$943K 0.02% 431
2024
Q3 		$20.2M Buy
181,000
+20,600
+13% +$2.26M 0.02% 444
2024
Q2 		$17.1M Sell
160,400
-1,200
-0.7% -$132K 0.02% 465
2024
Q1 		$19.5M Buy
161,600
+37,900
+31% +$4.64M 0.02% 465
2023
Q4 		$15.2M Buy
123,700
+19,100
+18% +$2.38M 0.02% 442
2023
Q3 		$13.5M Buy
104,600
+72,900
+230% +$9.71M 0.02% 444
2023
Q2 		$3.93M Sell
31,700
-14,700
-32% -$1.98M 0.01% 614
2023
Q1 		$6.79M Buy
46,400
+31,583
+213% +$4.67M 0.01% 526
2022
Q4 		$2.36M Sell
14,817
-659,500
-98% -$96.7M ﹤0.01% 693
2022
Q3 		$89.9M Buy
674,317
+20,300
+3% +$3.09M 0.15% 144
2022
Q2 		$102M Sell
654,017
-513,900
-44% -$79.1M 0.17% 126
2022
Q1 		$182M Buy
1,167,917
+617
+0.1% +$89.5K 0.24% 101
2021
Q4 		$149M Sell
1,167,300
-124
-0% -$16.3K 0.16% 148
2021
Q3 		$152M Buy
1,167,424
+1,075,675
+1,172% +$163M 0.17% 136
2021
Q2 		$16.3M Buy
91,749
+39,749
+76% +$6.89M 0.02% 454
2021
Q1 		$8.55M Buy
+52,000
New +$8.56M 0.01% 534
2020
Q3 		– Sell
-3,700
Closed -$409K – 1232
2020
Q2 		$409K Buy
3,700
+3,176
+606% +$351K ﹤0.01% 1090
2020
Q1 		$52K Sell
524
-14,199
-96% -$1.84M ﹤0.01% 1200
2019
Q4 		$2.2M Sell
14,723
-12,210
-45% -$1.66M ﹤0.01% 832
2019
Q3 		$3.45M Sell
26,933
-176,568
-87% -$23.7M 0.01% 742
2019
Q2 		$29M Buy
203,501
+37,099
+22% +$4.99M 0.06% 262
2019
Q1 		$23.8M Buy
166,402
+30,324
+22% +$3.96M 0.05% 342
2018
Q4 		$16.9M Buy
136,078
+115,431
+559% +$17.1M 0.04% 399
2018
Q3 		$3.47M Sell
20,647
-1,677
-8% -$288K 0.01% 917
2018
Q2 		$3.85M Sell
22,324
-12,647
-36% -$2.07M 0.01% 849
2018
Q1 		$5.28M Sell
34,971
-56,412
-62% -$8.28M 0.01% 779
2017
Q4 		$12.3M Buy
91,383
+31,604
+53% +$4.38M 0.02% 486
2017
Q3 		$8.74M Sell
59,779
-42,204
-41% -$6.38M 0.02% 537
2017
Q2 		$15.9M Buy
101,983
+19,332
+23% +$2.96M 0.04% 366
2017
Q1 		$12M Buy
82,651
+70,629
+587% +$9.2M 0.03% 411
2016
Q4 		$1.31M Sell
12,022
-22,200
-65% -$2.47M ﹤0.01% 729
2016
Q3 		$4.16M Buy
34,222
+34,201
+162,862% +$4.61M 0.02% 566
2016
Q2 		$3K Sell
21
-13,697
-100% -$2.02M ﹤0.01% 1070
2016
Q1 		$1.79M Buy
13,718
+12,594
+1,120% +$1.57M 0.01% 746
2015
Q4 		$158K Buy
1,124
+1,112
+9,267% +$154K ﹤0.01% 1029
2015
Q3 		$2K Sell
12
-793
-99% -$137K ﹤0.01% 1253
2015
Q2 		$142K Sell
805
-4,260
-84% -$765K ﹤0.01% 1086
2015
Q1 		$875K Buy
5,065
+4,565
+913% +$783K ﹤0.01% 872
2014
Q4 		$82K Buy
500
+300
+150% +$49.8K ﹤0.01% 1209
2014
Q3 		$32K Buy
+200
New +$30.7K ﹤0.01% 1164

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Canada Pension Plan Investment Board's JAZZ Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its Jazz Pharmaceuticals (JAZZ) stake by 9.4% in Q1 2026, buying an estimated $1.7M and bringing the position to 112,500 shares worth $21.3M. The position accounts for 0.01% of the portfolio, ranked #487.

Canada Pension Plan Investment Board first reported a position in JAZZ in Q3 2014 and has held it in 45 quarters since. The position peaked at $182M in Q1 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Canada Pension Plan Investment Board held 112,500 shares of Jazz Pharmaceuticals worth $21.3M as of Q1 2026.
  • Canada Pension Plan Investment Board bought 9,700 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.7M.
  • Jazz Pharmaceuticals made up 0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #487 holding.
  • Canada Pension Plan Investment Board first reported a position in Jazz Pharmaceuticals in Q3 2014 and has held it in 45 quarters since.
  • Canada Pension Plan Investment Board's Jazz Pharmaceuticals position peaked at $182M in Q1 2022.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.